TWI522338B - 用於治療發炎及疼痛的3-甲磺醯基丙腈 - Google Patents

用於治療發炎及疼痛的3-甲磺醯基丙腈 Download PDF

Info

Publication number
TWI522338B
TWI522338B TW100146435A TW100146435A TWI522338B TW I522338 B TWI522338 B TW I522338B TW 100146435 A TW100146435 A TW 100146435A TW 100146435 A TW100146435 A TW 100146435A TW I522338 B TWI522338 B TW I522338B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
pain
inflammation
ethyl acetate
compound
Prior art date
Application number
TW100146435A
Other languages
English (en)
Chinese (zh)
Other versions
TW201305093A (zh
Inventor
約瑟夫P 聖勞倫特
Original Assignee
歐樂鐵克工業公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 歐樂鐵克工業公司 filed Critical 歐樂鐵克工業公司
Publication of TW201305093A publication Critical patent/TW201305093A/zh
Application granted granted Critical
Publication of TWI522338B publication Critical patent/TWI522338B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/02—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C255/03—Mononitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW100146435A 2010-12-15 2011-12-15 用於治療發炎及疼痛的3-甲磺醯基丙腈 TWI522338B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42348510P 2010-12-15 2010-12-15

Publications (2)

Publication Number Publication Date
TW201305093A TW201305093A (zh) 2013-02-01
TWI522338B true TWI522338B (zh) 2016-02-21

Family

ID=46235178

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100146435A TWI522338B (zh) 2010-12-15 2011-12-15 用於治療發炎及疼痛的3-甲磺醯基丙腈

Country Status (11)

Country Link
US (8) US8476316B2 (cg-RX-API-DMAC10.html)
EP (1) EP2651407B1 (cg-RX-API-DMAC10.html)
JP (1) JP5932830B2 (cg-RX-API-DMAC10.html)
KR (1) KR101849813B1 (cg-RX-API-DMAC10.html)
CN (1) CN103260613B (cg-RX-API-DMAC10.html)
AU (1) AU2011344030B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013014583A2 (cg-RX-API-DMAC10.html)
CA (1) CA2820625C (cg-RX-API-DMAC10.html)
MX (1) MX2013006708A (cg-RX-API-DMAC10.html)
TW (1) TWI522338B (cg-RX-API-DMAC10.html)
WO (1) WO2012082718A2 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102002664B1 (ko) 2012-02-27 2019-07-23 오라텍 세라퓨틱스 엘엘씨 3-메틸술포닐프로피오니트릴의 제조 방법
AU2013271778B2 (en) * 2012-06-05 2018-03-01 Olatec Therapeutics Llc Pharmaceutical composition for treating inflammation and pain
US9481644B2 (en) 2012-06-05 2016-11-01 Olatec Therapeutics Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
JP6185575B2 (ja) 2012-06-05 2017-08-23 オラテック セラピューティクス リミティド ライアビリティ カンパニー 皮膚炎症性疾患の治療方法
CA2875053C (en) * 2012-06-05 2020-07-14 Olatec Industries Llc Pharmaceutical composition for treating inflammation and pain
MX368641B (es) 2012-06-11 2019-10-09 Olatec Ind Llc Compuestos para el tratamiento de inflamación y dolor.
US9114122B2 (en) 2012-06-14 2015-08-25 Olatec Industries Llc Compounds for treating inflammation and pain
WO2013188314A1 (en) * 2012-06-14 2013-12-19 Olatec Industries Llc Compounds for treating inflammation and pain
SI3021873T1 (sl) * 2013-07-18 2018-12-31 Xalud Therapeutics, Inc. Sestavek za zdravljenje vnetne sklepne bolezni
WO2015026851A1 (en) 2013-08-20 2015-02-26 Olatec Industries Llc Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
WO2015048328A1 (en) * 2013-09-26 2015-04-02 Olatec Industries Llc 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
US9440916B2 (en) 2013-09-26 2016-09-13 Olatec Therapeutics Llc 3, 4-bis-benzylsulfonylbutyronitrile and its pharmaceutical use
WO2015050878A1 (en) * 2013-10-01 2015-04-09 Olatec Industries Llc Pharmaceutical use of 3-benzylsulfonylpropionitrile
US9999610B2 (en) 2013-10-01 2018-06-19 Olatec Therapeutics Llc Pharmaceutical use of 3-benzylsulfonylpropionitrile
JP6426746B2 (ja) * 2013-10-07 2018-11-21 オラテック セラピューティクス リミティド ライアビリティ カンパニー 4−メチルスルホニル−2−ブテンニトリル及びその医薬上の使用
US9522878B2 (en) 2013-10-07 2016-12-20 Olatec Therapeutics Llc 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
WO2015081188A1 (en) * 2013-11-27 2015-06-04 Olatec Industries Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
ES2970485T3 (es) * 2017-01-06 2024-05-29 Olatec Therapeutics Llc Composición farmacéutica para su uso en el tratamiento de enfermedades cardiovasculares
US10273203B2 (en) 2017-04-11 2019-04-30 Olatec Therapeutics Llc Deuterated 3-methanesulfonylpropionitrile
AU2018313164A1 (en) * 2017-08-11 2020-03-19 Olatec Therapeutics Llc Method for treating Schnitzler's syndrome
WO2019152627A1 (en) * 2018-01-31 2019-08-08 Olatec Therapeutics Llc Method for preventing or treating alzheimer's disease
JP7229565B2 (ja) * 2018-03-21 2023-02-28 オラテック セラピューティクス リミティド ライアビリティ カンパニー メラノーマを治療するための方法
JP7209981B2 (ja) * 2019-05-31 2023-01-23 日本たばこ産業株式会社 触覚刺激に対する幸福感の評価を補助するための方法及び触覚刺激に対する幸福感を評価するためのデータ取得方法
CA3141407A1 (en) * 2019-06-17 2020-12-24 Charles A. Dinarello Method for treating asthma
EP4045009A4 (en) 2019-10-14 2023-11-01 Olatec Therapeutics LLC METHOD FOR TREATING BREAST CANCER
WO2022226495A1 (en) * 2021-04-22 2022-10-27 Olatec Therapeutics Llc Method for treating spinal cord injury
CN118436631B (zh) * 2024-05-08 2025-07-01 中国人民解放军军事科学院军事医学研究院 达泮舒腈在预防和/或治疗急性放射性肺损伤中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3041155A1 (de) * 1980-10-31 1982-06-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,3-dichlor-sulfonyl-acrylnitrilen
JPS58501722A (ja) 1981-10-16 1983-10-13 アボツト ラボラトリ−ズ 〔1↓−(2↓−ベンゾオキサゾリル)ヒドラジノ〕アルキルニトリル誘導体
US5175192A (en) * 1984-03-19 1992-12-29 The Rockefeller University Inhibitors of the advanced glycosylation of proteins and methods of use therefor
EP0355049A3 (en) 1988-08-18 1990-06-13 Zeneca Limited Heterocyclic compounds
US5348838A (en) 1991-07-31 1994-09-20 Kabushiki Kaisha Toshiba Photosensitive composition comprising alkali soluble binder and photoacid generator having sulfonyl group
KR100294084B1 (ko) 1998-06-02 2001-09-22 성재갑 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
KR100288190B1 (ko) 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
CN1528284A (zh) * 2003-10-06 2004-09-15 南昌弘益科技有限公司 蔊菜素滴丸及其制备方法
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
RU2642628C2 (ru) * 2006-02-16 2018-01-25 Анакор Фармасьютикалз, Инк. Бор-содержащие малые молекулы в качестве противовоспалительных средств
DE602006018367D1 (de) * 2006-03-20 2010-12-30 Olatec Ind Llc Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen
WO2008101060A1 (en) * 2007-02-14 2008-08-21 Logical Therapeutics, Inc. Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
JP5392261B2 (ja) 2008-08-12 2014-01-22 宇部興産株式会社 非水電解液及びそれを用いたリチウム電池
AU2010226794A1 (en) * 2009-03-18 2011-10-27 Olatec Industries Llc Compounds for treating inflammation and pain

Also Published As

Publication number Publication date
JP5932830B2 (ja) 2016-06-08
US8975297B2 (en) 2015-03-10
KR101849813B1 (ko) 2018-04-17
BR112013014583A2 (pt) 2016-09-20
US10080735B2 (en) 2018-09-25
KR20140030122A (ko) 2014-03-11
US9492420B2 (en) 2016-11-15
US20170119725A1 (en) 2017-05-04
CA2820625A1 (en) 2012-06-21
US9770428B2 (en) 2017-09-26
JP2014503533A (ja) 2014-02-13
CN103260613A (zh) 2013-08-21
CA2820625C (en) 2019-04-02
EP2651407A4 (en) 2014-06-04
US20120157524A1 (en) 2012-06-21
US20140228433A1 (en) 2014-08-14
WO2012082718A2 (en) 2012-06-21
US8476316B2 (en) 2013-07-02
US20200237706A1 (en) 2020-07-30
US20190133988A1 (en) 2019-05-09
EP2651407A2 (en) 2013-10-23
US10500184B2 (en) 2019-12-10
AU2011344030B2 (en) 2017-03-30
US20130172410A1 (en) 2013-07-04
US11229620B2 (en) 2022-01-25
TW201305093A (zh) 2013-02-01
MX2013006708A (es) 2013-09-13
WO2012082718A3 (en) 2012-10-26
US8829046B2 (en) 2014-09-09
EP2651407B1 (en) 2016-12-21
CN103260613B (zh) 2015-01-14
AU2011344030A1 (en) 2013-07-11
US20150231106A1 (en) 2015-08-20
US20180125807A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
US11229620B2 (en) 3-methanesulfonylpropionitrile for treating inflammation and/or pain
JP5587969B2 (ja) 炎症及び疼痛の処置用の化合物
JP6360163B2 (ja) 3,4−ビス−ベンジルスルホニルブタンニトリル及びその医薬上の使用
JP6426746B2 (ja) 4−メチルスルホニル−2−ブテンニトリル及びその医薬上の使用
JP6457502B2 (ja) 3−ベンジルスルホニルプロピオニトリルの医薬上の使用
CN105682460B (zh) 3,4-双-苄磺酰基丁腈及其药学用途
CN104394860A (zh) 用于治疗炎症和疼痛的化合物